Federal award (DEFINITIVE CONTRACT, fiscal year 2023)
Recipient: NEOVAXSYN INC
Awarding agency: Department of Health and Human Services / National Institutes of Health
Funding agency: Department of Health and Human Services / National Institutes of Health
Period of performance: 2021-07-01 to 2024-04-30
Current total value of award: $300000
Description: NANOVACCINE FOR ELICITING 10E8-LIKE BNABS AGAINST HIV-1